Due to COVID-19, new enrollment in research studies will be greatly limited.
If you are interested in a study, there may be a longer waiting period to receive a response to your inquiry.
View the guidance for research participants for additional information.
This study enrolls people who have been diagnosed with a subarachnoid hemorrhage (SAH), a type of brain bleed. The most common complication after SAH is blood vessel narrowing (vasospasm) in the brain. The purpose of this study is to find out if an investigational (experimental) device, which has not yet been approved by the FDA, is safe and can help treat patients who develop vasospasm after treatment of a SAH. Read More
People ages 18+
Developed vasospasm complications after treatment for SAH
This study enrolls children and youths ages 10-18 who are planning an elective surgery for treatment of Crohn’s or Ulcerative Colitis. The purpose of this study is to see how everything goes before, during, and after your surgery. Read More
Youths ages 10-18
Diagnosis of Crohn's or Ulcerative Colitis and undergoing elective surgery treatment
This study enrolls females ages 18-30 who like to run. The purpose of this study is to see how ?-Alanine effects a runner’s 800-meter time. ?-Alanine is an amino acid which is commercially available as a nutritional supplement. It has been shown to prevent muscles from becoming tired in weight training studies, but it has not been studied very well in runners. Read More
Recreational Runners able to run 800 meters between 2:30-4:30 minutes
This study enrolls healthy people between the ages of 18 and 39. The purpose of this study is to see if a device can measure how tired you become while walking and running at different speeds. Read More
This study enrolls adults aged 18-75 who are diagnosed with unwanted movements (chorea) associated with Huntington Disease (HD). The purpose of this study is to learn how well Valbenazine works in reducing these unwanted movements, and learn more about the safety and side effects of this medication. Valbenazine has already been approved by the FDA since April 2017 for the treatment of side effects related to other medications. Read More
Male and female adults aged 18-75 years
Diagnosis of Huntington Disease
Able to walk (assist devices such as cane or walker are allowed)
Negative pregnancy test for females (determined by blood work at first visit)
Sexually active adults of childbearing age must agree to consistently use birth control methods
Able to read and understand English
This study enrolls healthy, physically-active adults. The purpose of this study is to learn if exercising in a hot environment can better help the body adjust to higher altitudes where the air is thinner. Travel to higher altitudes takes weeks for the body to adjust, however, military personnel may not have enough time to adjust. This study may lead to valuable information that can benefit our troops. Read More
Healthy adults aged 18-29
Physically-active and in good fitness
This study enrolls people who have had a stroke in the past 2 weeks. This research is being done to figure out whether treatment for sleep apnea in people who have had a stroke or transient ischemic attack (TIA or "mini stroke"), improves recovery from stroke and helps prevent future stroke, heart problems, and death. Read More
Adults ages 18+.
Are at an inpatient at an enrolling site (Buffalo General Hospital or Gates Vascular Institute).
Have had an ischemic stroke or TIA within the past 14 days.
Use a CPAP machine.
This study enrolls adults and children who have had a recent kidney transplant. The purpose of this study is to improve outcomes after kidney donation and kidney transplantation by learning about how a specific gene may affect people. Read More
Adults or children who have undergone kidney transplantation or kidney donation.
Reside in US or Puerto Rico.
This study enrolls adults ages 65+ by invitation only. The purpose of this study is to learn whether reviewing a patients' medications will help to reduce falls. Read More
Adults ages 65+
Must fill prescriptions at the study site, have active prescriptions filled in the past four months, and be enrolled in a specific local Medicare plan.
Must be prescribed certain medications to be in the study
This study enrolls newborn infants with treatable retinopathy of prematurity (ROP). ROP is is one of the leading causes of childhood blindness worldwide. The purpose of this study is to learn if aflibercept (Eyelea) works to treat this condition. Read More
Children (newborn infants).
Gestational age at birth must be 32 weeks or less, birth weight must be 1500g or less
Must have retinopathy of prematurity (ROP) that has not yet been treated.
Must weigh at least 800 g